Gut-derived metabolites as treatment targets in chronic kidney disease—an avenue toward personalized medicine.
| Publicado en: | Pediatric Nephrology Vol. 40; no. 5; pp. 1505 - 1511 |
|---|---|
| Autores principales: | , |
| Formato: | commentary editorial Journal Article |
| Publicado: |
Springer Nature
May2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184038184&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 184038184 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0931041X EF1 jtl: Pediatric Nephrology issn: 0931041X maglogo: N pubinfo: dt: May2025 vid: 40 iid: 5 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 184038184 182255893 184038184 184038184 10.1007/s00467-024-06609-w 184038184 ppf: 1505 ppct: 6 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Gut-derived metabolites as treatment targets in chronic kidney disease—an avenue toward personalized medicine. aug: au: Holle, Johannes Bartolomaeus, Hendrik affil: https://ror.org/001w7jn25 Department of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité – Universitätsmedizin Berlin, Berlin, Germany sug: subj: Metabolites Gut Microbiota Metabolism Renal Insufficiency, Chronic Physiopathology Kidney Physiopathology Risk Assessment Treatment Outcomes Gut Microbiota Physiopathology Uremic Toxins Metabolism Enzymes Physiology Dietary Fiber Prebiotics Therapeutic Use Probiotics Therapeutic Use Research, Medical Microbiologic Phenomena Pediatric Care Child Development Renal Insufficiency, Chronic Complications Uremic Toxins Blood pubtype: Academic Journal doctype: commentary editorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|